221 related articles for article (PubMed ID: 2293503)
21. Prevention of post-transfusion graft-versus-host disease.
Tasaki T; Ohto H; Abe R
Fukushima J Med Sci; 1993 Dec; 39(2):109-11. PubMed ID: 7927133
[TBL] [Abstract][Full Text] [Related]
22. Transfusion-associated graft-versus-host disease: an overview and two case reports.
Spector D
Oncol Nurs Forum; 1995; 22(1):97-101. PubMed ID: 7708528
[TBL] [Abstract][Full Text] [Related]
23. [Transfusion-associated graft-versus-host disease].
Bojanić I; Cepulić BG
Lijec Vjesn; 2004; 126(1-2):39-47. PubMed ID: 15526751
[TBL] [Abstract][Full Text] [Related]
24. Bone marrow transplantation in miniature swine. III. Graft-versus-host disease and the effect of T cell depletion of marrow.
Sakamoto K; Sachs DH; Shimada S; Popitz-Bergez FA; Pennington LR; Pescovitz MD; McDonough MA; MacVittie TJ; Katz SI; Gress RE
Transplantation; 1988 May; 45(5):869-75. PubMed ID: 3285532
[TBL] [Abstract][Full Text] [Related]
25. Successful treatment of incipient graft rejection with donor leukocyte infusions, further proof of a graft versus host lymphohaemopoietic effect.
Díez-Martín JL; Gómez-Pineda A; Serrano D; Carrión R; Balsalobre P; Buño I
Bone Marrow Transplant; 2004 May; 33(10):1037-41. PubMed ID: 15064692
[TBL] [Abstract][Full Text] [Related]
26. Leucyl-leucine methyl ester-treated haploidentical donor lymphocyte infusions can mediate graft-versus-leukemia activity with minimal graft-versus-host disease risk.
Hsieh MH; Varadi G; Flomenberg N; Korngold R
Biol Blood Marrow Transplant; 2002; 8(6):303-15. PubMed ID: 12108916
[TBL] [Abstract][Full Text] [Related]
27. Transfusion-induced graft-versus-host disease after liver transplantation. Documentation using polymerase chain reaction with HLA-DR sequence-specific primers.
Wisecarver JL; Cattral MS; Langnas AN; Shaw BW; Fox IJ; Heffron TG; Rubocki RJ
Transplantation; 1994 Aug; 58(3):269-71. PubMed ID: 8053046
[TBL] [Abstract][Full Text] [Related]
28. Graft-facilitating doses of ex vivo activated gammadelta T cells do not cause lethal murine graft-vs.-host disease.
Drobyski WR; Majewski D; Hanson G
Biol Blood Marrow Transplant; 1999; 5(4):222-30. PubMed ID: 10465102
[TBL] [Abstract][Full Text] [Related]
29. [Transfusion associated graft versus host disease (TA-GVHD)].
Takahashi K
Ryoikibetsu Shokogun Shirizu; 1998; (22 Pt 3):605-8. PubMed ID: 9851229
[No Abstract] [Full Text] [Related]
30. Novel processes for inactivation of leukocytes to prevent transfusion-associated graft-versus-host disease.
Corash L; Lin L
Bone Marrow Transplant; 2004 Jan; 33(1):1-7. PubMed ID: 14647263
[TBL] [Abstract][Full Text] [Related]
31. Transfusion-associated graft-versus-host disease: a serious residual risk of blood transfusion.
Higgins MJ; Blackall DP
Curr Hematol Rep; 2005 Nov; 4(6):470-6. PubMed ID: 16232385
[TBL] [Abstract][Full Text] [Related]
32. Guidelines on gamma irradiation of blood components for the prevention of transfusion-associated graft-versus-host disease. BCSH Blood Transfusion Task Force.
Transfus Med; 1996 Sep; 6(3):261-71. PubMed ID: 8885157
[No Abstract] [Full Text] [Related]
33. [Indications for irradiated blood components: dose and side effects].
Eiermann TH
Beitr Infusionsther; 1993; 31():70-3. PubMed ID: 7693267
[TBL] [Abstract][Full Text] [Related]
34. [Transfusion-associated graft-vs-host disease].
Lillevang ST; Kristensen T
Ugeskr Laeger; 1992 Oct; 154(43):2964-8. PubMed ID: 1462384
[TBL] [Abstract][Full Text] [Related]
35. Transfusion-associated graft versus host disease (TAGVHD)--with reference to neonatal period.
Gokhale SG; Gokhale SS
J Matern Fetal Neonatal Med; 2015 Apr; 28(6):700-4. PubMed ID: 24871361
[TBL] [Abstract][Full Text] [Related]
36. White blood cell inactivation after treatment with riboflavin and ultraviolet light.
Marschner S; Fast LD; Baldwin WM; Slichter SJ; Goodrich RP
Transfusion; 2010 Nov; 50(11):2489-98. PubMed ID: 20529002
[TBL] [Abstract][Full Text] [Related]
37. [Transfusion associated graft versus host disease].
Takahashi K; Juji T
Rinsho Byori; 1991 Mar; Suppl 88():148-55. PubMed ID: 1856965
[No Abstract] [Full Text] [Related]
38. Advances in transfusion therapy.
Beck SJ
Clin Lab Sci; 1994; 7(4):225-31. PubMed ID: 10147432
[TBL] [Abstract][Full Text] [Related]
39. Special issues in transfusion medicine.
Harrison CR; Sawyer PR
Clin Lab Med; 1992 Dec; 12(4):743-57. PubMed ID: 1286562
[TBL] [Abstract][Full Text] [Related]
40. [Transfusion-associated graft-versus-host disease. Increased risk when using HLA matched donors].
Hovdenes J; Solheim BG
Tidsskr Nor Laegeforen; 1995 May; 115(12):1499-501. PubMed ID: 7770854
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
